Page 2 - hypertension_newsletter_Special_Servier_final

REFLECTIONS
Hypertension
Hypertension Special Edition – ESH 2024 Highlights

TABLE OF CONTENTS

KEY SESSIONS Hypertension

CLINICAL GUIDELINES
ESH 2024 Clinical practice guidelines for the management of arterial hypertension.
SYMPOSIA HIGHLIGHTS
Real-life hypertensive patients: Towards a holistic approach in clinical practice.

Why is it so difficult to reach the expected BP target in real-life patients?
Time to act to improve adherence in hypertension management: Bridging the gap between knowledge and action.

EPIDEMIOLOGY
Findings from May Measurement Month campaign.
• Awareness, treatment, and control of hypertension using opportunistic screening programs: Evidence from the
May Measurement Month campaign, 2017-2019. Razo C, et al.
• Comparing blood pressure control targets globally: An analysis of the May Measurement Month 2022 campaign
in 60 countries. Beaney T, et al.
Antihypertensive drug therapy and risk of dementia: Real-world evidence from a large old population. Rea F, et al.

Cumulative diastolic blood pressure burden in normal systolic blood pressure and cardiovascular disease. Cho SMJ, et al.
Hypertension, uncontrolled hypertension and resistant hypertension: Prevalence, comorbidities and prescribed
medications in 228,406 adults resident in urban areas. A population-based study. Sartorio A, et al.
SNAPSHOT epidemiological studies on CV risk management: Evidence from Bulgaria, Georgia and Serbia.
• Assessment of hypertension management in Bulgaria: Demographics, cardiovascular risk, and blood pressure
control discrepancies (SNAPSHOT STUDY)
• Hypertension management in Georgia: Bridging gaps in cardiovascular risk assessment and blood pressure
control (SNAPSHOT STUDY)
• Blood pressure and cholesterol control in hypertensive patients with dyslipidemia: A cross-sectional
epidemiological study in Serbia (SNAPSHOT STUDY)

COMORBIDITY CONSIDERATIONS
Assessment and management of patients with obesity and hypertension in European Society of Hypertension
excellence centres. A survey from the ESH working group on diabetes and metabolic conditions. Antza C, et al.

Single-pill combination antihypertensive therapy in hypertensive, obese patients: A prospective, epidemiological study
in Romania. Vintila AM, et al.
Achieved systolic blood pressure below 130 mmHg preserves kidney function in high-risk hypertensive patients
without cardiac hypertrophy but with proteinuria. Olsen E, et al.
HIGHLIGHTS FROM PLENARY SESSIONS

Cardiovascular renal protection – The concept and treatment perspectives.
Recent diabetes CVD trials on SGLT2 and GLP-1 and their effects on weight and hypertension.
Cardioavscular renal protection – Target blood pressure controversies.
Hypertension in Black Africans.